A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 139.83
GOOG 813.99
MSFT 64.50
BAC 22.55
FB 139.98

Recently Added

RAS-A 0.00
PANW 110.57
STRL 9.41
LAYN 8.45
NOA 4.35

Gaining Speed

PANW 110.57
RAS-A 0.00
TEX 28.75
PSA-S 0.00
XOM 81.04

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!